BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20615241)

  • 1. Novel molecular imaging platform for monitoring oncological kinases.
    Nyati S; Ross BD; Rehemtulla A; Bhojani MS
    Cancer Cell Int; 2010 Jul; 10():23. PubMed ID: 20615241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging of protein kinases.
    Zhang L; Bhojani MS; Ross BD; Rehemtulla A
    Cell Cycle; 2008 Feb; 7(3):314-7. PubMed ID: 18235250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Bioluminescent Activatable Reporter for Src Tyrosine Kinase Activity in Living Mice.
    Leng W; Li D; Chen L; Xia H; Tang Q; Chen B; Gong Q; Gao F; Bi F
    Theranostics; 2016; 6(4):594-609. PubMed ID: 26941850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging strategies for drug discovery and development.
    Gross S; Piwnica-Worms D
    Curr Opin Chem Biol; 2006 Aug; 10(4):334-42. PubMed ID: 16822702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current state of imaging protein-protein interactions in vivo with genetically encoded reporters.
    Villalobos V; Naik S; Piwnica-Worms D
    Annu Rev Biomed Eng; 2007; 9():321-49. PubMed ID: 17461729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals.
    Luker KE; Smith MC; Luker GD; Gammon ST; Piwnica-Worms H; Piwnica-Worms D
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12288-93. PubMed ID: 15284440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation.
    Hsu WC; Nenov MN; Shavkunov A; Panova N; Zhan M; Laezza F
    PLoS One; 2015; 10(2):e0117246. PubMed ID: 25659151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous delivery of D-luciferin by implanted micro-osmotic pumps enables true real-time bioluminescence imaging of luciferase activity in vivo.
    Gross S; Abraham U; Prior JL; Herzog ED; Piwnica-Worms D
    Mol Imaging; 2007; 6(2):121-30. PubMed ID: 17445506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach.
    Cheng AN; Lo YK; Lin YS; Tang TK; Hsu CH; Hsu JT; Lee AY
    EBioMedicine; 2018 Oct; 36():241-251. PubMed ID: 30293817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent biosensors - probing protein kinase function in cancer and drug discovery.
    Morris MC
    Biochim Biophys Acta; 2013 Jul; 1834(7):1387-95. PubMed ID: 23376184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring molecular-specific pharmacodynamics of rapamycin in vivo with inducible Gal4->Fluc transgenic reporter mice.
    Pan MH; Lin J; Prior JL; Piwnica-Worms D
    Mol Cancer Ther; 2010 Oct; 9(10):2752-60. PubMed ID: 20858726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoproteomics for the discovery of kinases as cancer biomarkers and drug targets.
    Yu LR; Issaq HJ; Veenstra TD
    Proteomics Clin Appl; 2007 Sep; 1(9):1042-57. PubMed ID: 21136756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One reporter for in-cell activity profiling of majority of protein kinase oncogenes.
    Gudernova I; Foldynova-Trantirkova S; Ghannamova BE; Fafilek B; Varecha M; Balek L; Hruba E; Jonatova L; Jelinkova I; Kunova Bosakova M; Trantirek L; Mayer J; Krejci P
    Elife; 2017 Feb; 6():. PubMed ID: 28199182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative and Dynamic Imaging of ATM Kinase Activity.
    Nyati S; Young G; Ross BD; Rehemtulla A
    Methods Mol Biol; 2017; 1596():131-145. PubMed ID: 28293885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and Efficient Synthetic Assembly of Multiplex Luciferase Reporter Plasmids for the Simultaneous Monitoring of Up to Six Cellular Signaling Pathways.
    Sarrion-Perdigones A; Gonzalez Y; Venken KJT
    Curr Protoc Mol Biol; 2020 Jun; 131(1):e121. PubMed ID: 32539183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging of phosphorylation events for drug development.
    Chan CT; Paulmurugan R; Reeves RE; Solow-Cordero D; Gambhir SS
    Mol Imaging Biol; 2009; 11(3):144-58. PubMed ID: 19048345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging of glycogen synthase kinase-3beta and casein kinase-1alpha kinases.
    Nyati S; Ranga R; Ross BD; Rehemtulla A; Bhojani MS
    Anal Biochem; 2010 Oct; 405(2):246-54. PubMed ID: 20561505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red-Shifted Firefly Luciferase Optimized for
    Dorsaz S; Coste AT; Sanglard D
    Front Microbiol; 2017; 8():1478. PubMed ID: 28824601
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial MicroRNAs as Novel Secreted Reporters for Cell Monitoring in Living Subjects.
    Ronald JA; D'Souza AL; Chuang HY; Gambhir SS
    PLoS One; 2016; 11(7):e0159369. PubMed ID: 27442530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.